Browse CATs

Browse CATs  internal medicine  cardiology  deep vein thrombosis

Diagnosis Economics Harm/ aetiology Prognosis Therapy Heparin Warfarin Prophylaxis

Deep vein thrombosis danaparoid was not clearly better than heparin. Level of evidence 1b- Expiry Date May 2003 Deep vein thrombosis patients on LMWH could probably be sent home safely. Level of evidence 1b- Expiry Date May 2003 Deep vein thrombosis patients on LMWH could probably be sent home safely. Level of evidence 1b- Expiry Date May 2003 Deep vein thrombosis LMWH was not clearly as effective as warfarin for long-term anticoagulation. Level of evidence 1b- Expiry Date June 2003 Deep vein thrombosis LMWH is safer than unfractionated heparin. Level of evidence 1a Expiry Date December 2003 Deep vein thrombosis LMWH was safe and effective in outpatients. Level of evidence 1b- Expiry Date December 2003 Deep vein thrombosis LMWH decreases recurrence. Level of evidence 1a Expiry Date December 2003 Venous thromboembolism fewer deaths and bleeds on LMWH compared with heparin. Level of evidence 1a Expiry Date May 2003 Venous thromboembolism and warfarin contraindication fewer vertebral fractures on long term LMWH. Level of evidence 1b- Expiry Date May 2003 Venous thromboembolism and warfarin contraindication fewer vertebral fractures on long term LMWH. Level of evidence 1b- Expiry Date May 2003 Venous thromboembolism LMWH long term is probably as safe as vitamin K antagonists Level of evidence 1a Expiry Date October 2003 Venous thromboembolism LMWH was probably as good as heparin. Level of evidence 1b- Expiry Date September 2003